Impact of disease duration and beta cell reserve on the efficacy of iGlarLixi in patients with type 2 diabetes: the LixiLan-G trial Article

Web of Science: 000485303803204
Industry Collaboration International Collaboration

Cited authors

  • Del Prato, S.; Frias, J. P.; Blonde, L.; Aroda, V. R.; Shehadeh, N.; Henry, R.; Saremi, A.; Dex, T.; Niemoeller, E.; Souhami, E.; Liu, M.; Rosenstock, J.

Authors

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0012-186X

Start page

  • S427

End page

  • S427

Volume

  • 62